Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1997-07-30
1999-03-02
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
534 10, 534 11, 534 14, 424 177, A61K 5104, C07F 500
Patent
active
058766936
ABSTRACT:
A compound and method of making a compound for use as a diagnostic or therapeutic pharmaceutical comprises a functionalized hydroxyalkyl phosphine ligand and a metal combined with the ligand.
REFERENCES:
patent: 4419339 (1983-12-01), Neirinckx
patent: 4439196 (1984-03-01), Higuchi
patent: 4446224 (1984-05-01), DeCant, Jr. et al.
patent: 4447233 (1984-05-01), Mayfield
patent: 4475196 (1984-10-01), La Zor
patent: 4486194 (1984-12-01), Ferrara
patent: 4487603 (1984-12-01), Harris
patent: 4795626 (1989-01-01), Deutsch et al.
Chatt et al. "Rhodium (I), Rhodium (II), Palladium (II) Complexes containing ligands of the type PRnQ3-n," J. Chem. Soc., (19), pp. 2021-2028 1973.
Chianelli et al. "99mTc-interlikin-2: a new radiopharmaceutical for the in vivo detection of lymphocytic infiltration" J Nucl Biol Med 38:476 (1994).
Deutsch, "Aspects of the chemistry of technetium phosphine complexes" Radiochim Acta 63:195-197, (1993).
Ellis et al., "Water-soluble tris(Hydroxymethyl) phosphine complexes with nickel, palladim and platinum . . . " Inorg Chem 31:3026-3033, (1992).
Fritzberg et al., "Specific and stable labeling of antibodies with 99mTc with a dimide dithiolate chelating agent" Proc. Natl. Acad. Sci., USA 85:4025-4029, (1988).
Gustavson et al., "Synthesis of a new class of Tc-chelating agents . . . " Tetrahedron Lett, vol. 32, No. 40, pp.5485-5488 (1991).
Jurisson et al., "Coordination compounds in nuclear medicine" Chem Rev 93:1137-1156, (1993).
Kelly et al., Technetium-99m-Tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging J Nucl Med 34:222-227 (1993).
Knight et al., "Thrombus imaging with 99mTc synthetic peptides based upon the binding domain of a monoclonal antibody . . . " J Nucl Med 35:282-288, (1994).
Lister-James et al., "A structure-activity-relationship (SAR) study of somatostatin receptor-binding peptides . . . " J Nucl Med, 35:257-258P, (1994).
Marmion et al., "Radiopharmaceutical development of TechneScan Q-12" J Nucl Biol Med 38:455-456, (1994).
Meares et al., "Chelate radiochemistry: cleavable linkers lead to altered levels of radioactivity in the liver" Int J Cancer 2:99-102, (1988).
Maina et al.,"Synthesis, radiochemical and biological evaluation of
Nock et al., "99mTc-N4-Lys-Biotin, a new biotin derivative useful for pretargeted avidin-biotin immunoscintigraphy . . . " J Nucl Biol Med 38:460, (1994).
Nowotnik and Nunn, "Technetium SPECT agents for imaging heart and brain" DN and P 5:174-183, (1992).
Parker, "Tumour targeting with radiolabeled macrocycle-antibody conjugates" Chem. Soc. Rev. 19:271-291, (1990).
Pasqualini et al., "Bis(dithiocarbamato)nitrido technetium-99m radidpharmaceuticals: a class of neutral myocardial . . . " J. Nucl. Med. 35: 334-340 (1994).
Rao et al., "Kinetics and mechanism of reactions of S-protected dithiol monoaminemonoamide (MAMA) ligands with technetium" Nucl Med Biol, 19:889-895, (1992).
Troutner, "Chemical and physical properties of radionuclides" Nucl Med Biol 14:171 (1987).
Volkert et al., "Therapeutic radionuclides: production and decay property considerations" J Nucl Med 32:174-185, (1991).
Wilbur, "Radiohalogenation of proteins: an overview of radionuclides, labeling methods and reagents for conjugate labeling" Bioconj Chem 3:433-470, (1992).
Abrams et al., "Technetium-99m-human polyclonal IgG radiolabeled via the hydrzaino nicotinamide . . . " J Nucl Med 31:2022-2028, (1990).
Abrams et al. "Synthesis and crystal and molecular structure of a technetium-hydralazino complex . . . " Inorg Chim Acta 173:1333-135, (1990).
Katti Kattesh V.
Katti Kavita K.
Ketring Alan R.
Reddy V. Sreenivasa
Singh Prahlad R.
Hartley Michael G.
Hollinden Gary E.
The Curators of the University of Missouri
LandOfFree
Hydroxyalkyl phosphine compounds for use as diagnostic and thera does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hydroxyalkyl phosphine compounds for use as diagnostic and thera, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxyalkyl phosphine compounds for use as diagnostic and thera will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-419549